Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients

被引:81
作者
Yakaryilmaz, Fahri
Gurbuz, Oguz Alp
Guliter, Sefa
Mert, Ali
Songur, Yildiran
Karakan, Tarkan
Keles, Hatice
机构
[1] Kirikkale Univ, Fac Med, Dept Gastroenterol, Kirikkale, Turkey
[2] Kirikkale Univ, Fac Med, Dept Internal Med, Kirikkale, Turkey
[3] Gazi Univ, Fac Med, Dept Gastroenterol, TR-06620 Ankara, Turkey
[4] Yildrim Beyazit Educ & Res Hosp, Minist Hlth, Dept Microbiol, Ankara, Turkey
[5] Suleyman Demirel Univ, Fac Med, Dept Gastroenterol, Isparta, Turkey
关键词
hemodialysis; occult hepatitis; chronic renal failure;
D O I
10.1080/08860220600925602
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and Objective. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are important causes of morbidity and mortality in maintenance hemodialysis patients. Although their exact prevalence is not known, HBV and HCV viral infections and occult viral hepatitis are frequent in these patients. This study aimed to determine the prevalence of occult HBV and HCV infections in maintenance hemodialysis patients. Materials and Methods. One hundred and eighty-eight end-stage renal disease patients on maintenance hemodialysis (100 male, mean age 49 29 [16-80] years, and mean duration of hemodialysis 98 66 [12-228] months) were enrolled in this study. Scrological markers for HBV and HCV were determined with immunoenzymatic assay (ELISA) by using commercial diagnostic kits (Access and BioRad, Beckman-Coulter). HCV-RNA (Cobas Amplicor HCV kit) and HBV-DNA (Artus GmbH HBV kit) were determined quantitatively by polymerase chain reaction. Results. Among the patients screened, 25 (13.3%) had HBV infection alone and 38 (20.2%) had HCV infection alone, while seven (3.7%) had dual infection of both viruses. Serological markers for occult hepatitis B and occult hepatitis C were positive in five (2.7%) and nine (4.8%) of the patients, respectively. Isolated anti-HBc was positive in 12 (6.4%) of all patients, three (7.9%) of the patients with anti-HCV and two (40%) of the patients with occult hepatitis B. Isolated anti-HBc positivity was more frequent in patients with occult hepatitis B than in those without (40% [2/5] vs. 5.5% [10/183], p=0.002). None of the patients with HCV had occult hepatitis B. Conclusions. Both occult and non-occult forms of HCV infection are more prevalent than HBV infection in hemodialysis patients. Especially the patients with isolated anti-HBc positivity should be tested for probable occult hepatitis B infection.
引用
收藏
页码:729 / 735
页数:7
相关论文
共 58 条
  • [1] PREVALENCE OF ANTI-HCV AMONG HEMODIALYSIS-PATIENTS IN TURKEY - A MULTICENTER STUDY
    AKPOLAT, T
    ARIK, N
    GUNAYDIN, M
    UTAS, C
    DILEK, K
    CAGLAR, S
    CANDAN, F
    SULEYMANLAR, G
    PAYDAS, S
    SEN, S
    KURSAT, S
    YEKSAN, M
    AKOGLU, E
    BORAN, M
    ARINSOY, T
    BOZFAKIOGLU, S
    CAMSARI, T
    TONBUL, Z
    VURAL, A
    ATAMAN, R
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (04) : 479 - 480
  • [2] Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia
    Almawi, WY
    Qadi, AA
    Tamim, H
    Ameen, G
    Bu-Ali, A
    Arrayid, S
    Jaoude, MMA
    [J]. TRANSPLANTATION PROCEEDINGS, 2004, 36 (06) : 1824 - 1826
  • [3] ARANKALLE VA, 1992, J ASSOC PHYSICIAN I, V40, P562
  • [4] HEPATITIS C-VIRUS (HCV) ANTIBODIES IN PATIENTS AFTER KIDNEY-TRANSPLANTATION
    BAUR, P
    DANIEL, V
    POMER, S
    SCHEURLEN, H
    OPELZ, G
    ROELCKE, D
    [J]. ANNALS OF HEMATOLOGY, 1991, 62 (2-3) : 68 - 73
  • [5] Berry N, 1998, INDIAN J MED MICROBI, V16, P44
  • [6] Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection
    Besisik, F
    Karaca, Q
    Akyüz, F
    Horosanli, S
    Önel, D
    Badur, S
    Sever, MS
    Danalioglu, A
    Demir, K
    Kaymakoglu, S
    Çakaloglu, Y
    Ökten, A
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 (04) : 506 - 510
  • [7] Bozdayi Gulendam, 2002, Mikrobiyoloji Bulteni, V36, P291
  • [8] BRUGUERA M, 1990, J CLIN GASTROENTEROL, V20, P5042
  • [9] HIGH PREVALENCE OF HEPATITIS-C VIRUS (HCV) RNA IN DIALYSIS PATIENTS - FAILURE OF COMMERCIALLY AVAILABLE ANTIBODY TESTS TO IDENTIFY A SIGNIFICANT NUMBER OF PATIENTS WITH HCV INFECTION
    BUKH, J
    WANTZIN, P
    KROGSGAARD, K
    KNUDSEN, F
    PURCELL, RH
    MILLER, RH
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (06) : 1343 - 1348
  • [10] Cabrerizo M, 1997, J AM SOC NEPHROL, V8, P1443